MedPath

To study the Efficacy of Thyrocompound in the management of Subclinical Hypothyroidism.

Phase 2
Conditions
Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism
Registration Number
CTRI/2024/07/070144
Lead Sponsor
Dr Varsharani Arjun Chaudhari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of grade 1 subclinical hypothyroidism having serum TSH level within range of 4.9 mL/L to 10 mL/L.

2.Patients having 3 clinical symptoms of subclinical hypothyroidism among following-

tiredness weakness lethargy dry skin and hair cold intolerance loss of hairs difficulty in concentration and poor memory weight gain with poor appetite constipation hoarseness of voice dypsonea menorrhagia puffy face hands and feet bradycardia

Exclusion Criteria

1. Grade 2 subclinical hypothyroidism serum TSH level more than 10 mL/L.

2. Primary hypothyroidism caused due to thyroidectomy radioactive Iodine Therapy for Graves disease or Nodular Goiter. Radio therapy for head and neck cancer.

3. Secondary hypothyroidism

4. Patients Having history of medications like Amiodarone, Interleukin -2 Kinase inhibitor and lithium

5. Patients undergoing any known hormonal therapy other than Levothyroxine

6. Patients suffering from chronic anemia

7. Co morbid patients like known case of HTN, DM, IHD, Angina , MI

8. Patients receiving anti retro viral therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath